Benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors

US9765030B2 · kind B2 · utility

Assignee

• DR. REDDY'S LABORATORIES LIMITED · IN

Inventors

• Anima Baruah · Hyderabad, IN
• Dibyendu De · Suwanee, US
• Ish Khanna · Vernon Hills, US
• Sivaram Pillarisetti · Norcross, US
• Santanu Maitra · Hyderabad, IN
• Christopher W. Alexander · Norcross, US
• Jennepalli Sreenu · Darsi, IN
• Indu Dager · Ghaziabad, IN
• Shanavas Alikunju · Darsi, IN

Key dates

• Filing date: Oct 14, 2013
• Grant date: Sep 19, 2017
• Expiry date: Oct 14, 2033

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D498/04
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The present invention provides, among other things, new benzylamine compounds, compositions comprising benzylamine compounds, methods of making benzylamine compounds, and methods of using benzylamine compounds for treating or preventing a variety of conditions or diseases associated with lipoprotein metabolism.